U.S. Food and Drug Administration's Guidance Regarding Morcellation of Leiomyomas: Well-Intentioned, But Is It Harmful for Women?

@article{Parker2016USFA,
  title={U.S. Food and Drug Administration's Guidance Regarding Morcellation of Leiomyomas: Well-Intentioned, But Is It Harmful for Women?},
  author={William H Parker and Andrew M. Kaunitz and Elizabeth Anna Pritts and David L. Olive and Eva Chalas and Daniel L. Clarke-Pearson and Jonathan S. Berek},
  journal={Obstetrics and gynecology},
  year={2016},
  volume={127 1},
  pages={18-22}
}
The U.S. Food and Drug Administration (FDA) is warning against the use of laparoscopic power morcellators in the majority of women undergoing myomectomy or hysterectomy for the treatment of leiomyomas because of the concern for inadvertent spread of tumor cells if an undiagnosed cancer were present. The authors, representing a 45-member review group, reviewed the current literature to formulate prevalence rates of leiomyosarcoma in women with presumed leiomyomas and to asses reliable data… CONTINUE READING

From This Paper

Topics from this paper.
8 Citations
11 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 11 references

Similar Papers

Loading similar papers…